Iran Antibiotic Manufacturing Company (BIUTIK) balance sheet
Assets, liabilities and equity at the close of each period
- Ticker
- BIUTIK
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Property, plant and equipment | 4,116,711 | 3,969,326 | 951,009 | 632,632 | 468,013 | 366,901 |
| Intangible assets | 3,177 | 4,554 | 6,541 | 7,695 | 8,739 | 2,706 |
| Long-term investments | 44 | 44 | 24 | 13 | 0 | 0 |
| Total non-current assets | 4,119,932 | 3,973,924 | 957,574 | 640,340 | 476,752 | 369,607 |
| Orders and prepayments | 7,868,989 | 3,938,384 | 1,833,979 | 5,096,107 | 210,601 | 161,528 |
| Inventory of materials and goods | 1,905,614 | 982,675 | 1,812,534 | 496,942 | 1,373,063 | 1,032,303 |
| Trade and other receivables | 11,887,008 | 9,940,267 | 7,998,161 | 2,093,581 | 1,868,901 | 804,414 |
| Cash | 415,466 | 2,390,935 | 123,373 | 1,695,505 | 358,035 | 72,238 |
| Total current assets | 22,077,077 | 17,252,261 | 11,793,047 | 9,482,135 | 3,810,614 | 2,118,583 |
| Total assets | 26,197,009 | 21,226,185 | 12,750,621 | 10,122,475 | 4,287,366 | 2,488,190 |
| Capital | 802,900 | 802,900 | 802,900 | 802,900 | 702,900 | 702,900 |
| Increase in capital in progress | 999,500 | 0 | 0 | 0 | 0 | 0 |
| Legal reserve | 80,290 | 80,290 | 80,290 | 80,290 | 70,290 | 70,290 |
| Revaluation surplus of assets | 2,972,596 | 2,972,596 | 0 | 0 | 0 | 0 |
| Retained earnings (accumulated losses) | 5,271,045 | 2,414,531 | - | 563,425 | 519,802 | 473,686 |
| Treasury shares | -39,186 | -40,155 | -35,092 | 0 | 0 | 0 |
| Total equity | 10,101,775 | 6,240,573 | 3,525,219 | 1,446,615 | 1,292,992 | 1,246,876 |
| Employee end-of-service benefits provision | 432,157 | 292,896 | 208,361 | 205,278 | 151,229 | 136,165 |
| Total non-current liabilities | 432,157 | 292,896 | 208,361 | 205,278 | 151,229 | 136,165 |
| Trade and other payables | 3,587,005 | 2,897,340 | 2,762,024 | 2,465,134 | 1,195,022 | 119,429 |
| Tax payable | 1,700,016 | 1,810,031 | 192,415 | 75,448 | 152,846 | 100,533 |
| Dividends payable | 5,794,056 | 4,769,627 | 3,161,568 | 2,241,697 | 971,596 | 447,970 |
| Total current liabilities | 15,663,077 | 14,692,716 | 9,017,041 | 8,470,582 | 2,843,145 | 1,105,149 |
| Total liabilities | 16,095,234 | 14,985,612 | 9,225,402 | 8,675,860 | 2,994,374 | 1,241,314 |
| Total equity and liabilities | 26,197,009 | 21,226,185 | 12,750,621 | 10,122,475 | 4,287,366 | 2,488,190 |
Reporting periods
29 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.